Cargando…
Cathelicidin Treatment Silences Epithelial–Mesenchymal Transition Involved in Pulmonary Fibrosis in a Murine Model of Hypersensitivity Pneumonitis
Pulmonary fibrosis is becoming an increasingly common pathology worldwide. Unfortunately, this disorder is characterized by a bad prognosis: no treatment is known, and the survival rate is dramatically low. One of the most frequent reasons for pulmonary fibrosis is hypersensitivity pneumonitis (HP)....
Autores principales: | Lemieszek, Marta Kinga, Golec, Marcin, Zwoliński, Jacek, Dutkiewicz, Jacek, Milanowski, Janusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659202/ https://www.ncbi.nlm.nih.gov/pubmed/36361827 http://dx.doi.org/10.3390/ijms232113039 |
Ejemplares similares
-
Beneficial impact of cathelicidin on hypersensitivity pneumonitis treatment—In vivo studies
por: Lemieszek, Marta Kinga, et al.
Publicado: (2021) -
A Scoping Analysis of Cathelicidin in Response to Organic Dust Exposure and Related Chronic Lung Illnesses
por: Golec, Marcin, et al.
Publicado: (2022) -
Hypersensitivity Pneumonitis: Correct Identification of Causative Microbial Agents Is Essential for Efficient Diagnosis and Prevention
por: Dutkiewicz, Jacek, et al.
Publicado: (2023) -
Hypersensitivity pneumonitis
por: Lacasse, Yves, et al.
Publicado: (2006) -
Hypersensitivity pneumonitis: An infrequent cause of chronic lung fibrosis in Africa?
por: Wong, M L
Publicado: (2022)